Protein Microarrays Market worth $1.78 billion by 2030
The report "Protein Microarrays Market by Offering (Products, Services), Type (Biochips, Microarray Instruments), Application (Clinical, Drug Discovery) - Global Forecast to 2030” is projected to grow from USD 1.00 billion in 2025 and to reach USD 1.78 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 12.3% during the forecast period.
Browse 983 market data Tables and 57 Figures spread through 781 Pages and in-depth TOC on Protein Microarrays Market by Offering (Products, Services), Type (Biochips, Microarray Instruments), Application (Clinical, Drug Discovery) - Global Forecast to 2030”
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/protein-microarrays-market-25942618.html
The protein microarrays market is expected to experience significant growth, driven by several key factors, including integration with multi-omics workflows and the need for high-throughput biomarker discovery.
“The products segment accounted for the largest market share in 2024.”
By offering, the protein microarrays market is segmented into products and services. In 2024, the products segment commanded the largest market share, driven by surging demand for standardized kits, high-density biochip slides, automated fluorescence scanners, and ready-to-use reagents. These solutions deliver rapid biomarker screening, superior assay reproducibility, and seamless integration into high-throughput workflows, enabling biopharma R&D, clinical validation labs, and academic researchers to accelerate protein interaction studies and companion diagnostic development while minimizing reliance on outsourced services.
“The clinical diagnostics segment held the largest market share in 2024.”
By application, the market is divided into clinical diagnostics, drug discovery and development, and other applications. Of these, the clinical diagnostics segment accounted for the largest market share in 2024, owing to the use of multiplex biomarker panels, which facilitate early disease detection, monitor responses to therapy, and enable personalized treatment strategies for oncology, autoimmune disorders, and infectious diseases. High-throughput arrays offer outstanding sensitivity for detecting low-abundance proteins in serum and tissue samples, supporting liquid biopsy workflows and companion diagnostics. Regulatory approvals and established reimbursement pathways are accelerating adoption in hospital laboratories, positioning protein microarrays as essential tools in precision medicine and reducing reliance on single-plex assays.
“North America accounted for the largest share of the global protein microarrays market in 2024.”
The protein microarrays market is segmented based on region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America leads the market, driven by its dominant biotech/pharma ecosystem, substantial NIH and venture funding, innovation hubs like Boston and San Diego, and rapid adoption of high-plex arrays for biomarker validation, precision oncology diagnostics, and drug target screening across academic institutions, clinical labs, and industry leaders.
Key players in the protein microarrays market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies (US), Illumina (US), Merck KGaA (Germany), Qiagen (Netherlands), PerkinElmer, Inc. (US), and Waters Corporation (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Protein Microarrays Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
